24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Genes Could Help Drive Febrile Convulsions in KidsScientists Regrow Frog's Lost Leg: Could Human Amputees Someday Do the Same?Almost 1 in 10 U.S. Lung Transplants Now Due to COVIDAny Change to Menstrual Cycle After COVID Vaccine Is Minor, Temporary: StudiesModerna Begins Testing Booster Shot Aimed at OmicronNewer Rheumatoid Arthritis Drug Might Raise Heart, Cancer RisksScientists Watch, Worry About New 'Stealth' Version of Omicron VariantCommon Gout Drug Is Safe in Patients With Kidney IssuesScientists Discover How the 'Mono' Virus Might Trigger MSSaline IV Drip Just as Good as Pricier Options in Hospital ICUs: StudyCOVID Infection Unlikely From Hospital Surfaces: StudyMany People With Asthma Have Mixed Feelings About Masks: PollMore Proof That COVID Vaccines Won't Harm FertilityMore Than 1 Million U.S. Kids Diagnosed With COVID in Single WeekBiden Administration Withdraws Vaccine Mandate for Large EmployersSurvivors of Severe COVID Face Higher Odds for Another Hospitalization Soon AfterOmicron Batters Already Strained U.S. Hospitals3 Factors Helped Teens Stay Mentally Healthy During PandemicVaccination Key to 'Super Immunity' Against COVID-19EU Eases COVID-19 Travel Rules Within the Bloc for Fully VaccinatedPandemic to Endemic: Is a New Normal Near?Pfizer Begins Testing a COVID Vaccine Targeted to OmicronCOVID Is Proving More Lethal for Children in Africa3 Reasons Why Trying to Get COVID Is a Bad IdeaFree N95 Masks Begin Arriving in U.S. PharmaciesOmicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level OffFDA Limits Use of Two COVID Antibody TreatmentsCOVID Can Affect Brains of Hospitalized KidsCOVID Vaccine Hesitancy Falling Faster Among Black Americans Than WhitesEngland to Lift Travel Restrictions for Vaccinated VisitorsAre Pins or a Cast Better for a Broken Wrist?FDA May Limit Use of Two COVID Antibody TreatmentsSome Patients With Macular Degeneration Could Stop Monthly Eye InjectionsYou Don't Have to Smoke to Get Lung CancerCOVID Vaccine Won't Affect Fertility, But Getting COVID MightThree New Studies Confirm Power of Booster Shots Against OmicronHit Your Head? Look for These Warning Signs of ConcussionArthritis & the COVID Vaccine: What You Need to KnowCOVID Boosters Keep Older Americans Out of Hospitals: CDCCOVID Rapid Test Makers Struggling to Meet DemandAHA News: A Healthy Thyroid Can Be Key to a Healthy HeartAnother Study Finds Vaccine Booster 'Neutralizes' Omicron'Artificial Pancreas' Can Help Kids With Type 1 DiabetesGetting Back to Sports After Recovering from COVID-19Side Effects From New Cancer Meds Have Silver LiningDengue Virus Makes Mosquitoes Bite More OftenNew Clues to Why Some Develop 'Brain Fog' After COVIDVaccination Plus Prior Infection Best Defense Against COVIDBinge-Watching Could Raise Your Blood Clot RiskIs a Night in the Hospital Necessary After Hip, Knee Replacement?
Questions and AnswersLinks
Related Topics

Diabetes

1 in 10 People With COVID Still Infectious After 10 Days: Study

HealthDay News
by Robert Preidt
Updated: Jan 14th 2022

new article illustration

FRIDAY, Jan. 14, 2022 (HealthDay News) -- One in 10 people with COVID-19 could still be infectious beyond 10 days, and some could remain so for as long as two months, a new study suggests.

U.K. researchers reported that a new test can detect whether the coronavirus is potentially still active. They used it to analyze samples from 176 people who had tested positive on standard PCR tests.

After 10 days, 13% of the people had levels of active virus, indicating they could potentially still be infectious. These levels continued in some of the participants for up to 68 days, according to the study.

"While this is a relatively small study, our results suggest that potentially active virus may sometimes persist beyond a 10-day period, and could pose a potential risk of onward transmission," said Lorna Harries, a University of Exeter Medical School professor who oversaw the study.

"Furthermore, there was nothing clinically remarkable about these people, which means we wouldn't be able to predict who they are," Harries added in a university news release.

Standard PCR tests check for the presence of viral fragments and can reveal if someone recently had the coronavirus, but not whether it's still active. The new test — which is not yet available — only gives a positive result when the virus is active and potentially infectious.

The results were published online Dec. 7 in the International Journal of Infectious Diseases.

Although more research is still needed, the new test could be useful in certain settings to protect vulnerable people, the researchers suggested.

In some settings, such as residential care facilities, people returning after illness and continuing to be infectious after 10 days could pose a serious public health risk, according to study lead author Merlin Davies, also of the University of Exeter Medical School.

"We may need to ensure people in those settings have a negative active virus test to ensure people are no longer infectious. We now want to conduct larger trials to investigate this further," Davies added.

In the United States, current quarantine guidelines allow people who've tested positive for COVID-19 to come out of isolation after five days if they are symptom-free or their symptoms are resolving (without fever for 24 hours). They should wear masks for the next five days, the U.S. Centers for Disease Control and Prevention says.

More information

The U.S. Centers for Disease Control and Prevention has more on protecting yourself and others from COVID-19.

SOURCE: University of Exeter, news release, Jan. 13, 2022